Elucidating the precise pharmacological system of action (MOA) of naturally occurring compounds could be difficult. Although Tarselli et al. (60) made the very first de novo artificial pathway to conolidine and showcased this Obviously happening compound properly suppresses responses to both equally chemically induced and inflammation-derived pain,